Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
682.94
619.55
514.83
393.79
261.21
192.29
53.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
682.94
619.55
514.83
393.79
261.21
192.29
53.16
Raw Material Cost
265.98
203.63
149.27
101.09
73.24
63.90
16.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
104.74
85.24
36.08
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.50
2.99
0.60
0.00
0.83
0.28
0.01
Selling and Distribution Expenses
242.96
209.00
181.63
0.00
82.67
72.89
34.96
Other Expenses
7.77
9.15
8.09
0.00
-5.74
-5.52
-2.56
Total Expenditure (Excl Depreciation)
591.15
507.12
412.37
101.09
204.13
167.09
62.41
Operating Profit (PBDIT) excl Other Income
91.8
112.4
102.5
292.7
57.1
25.2
-9.200000000000001
Other Income
33.01
49.80
75.81
0.00
42.98
25.13
9.60
Operating Profit (PBDIT)
221.44
223.17
222.86
143.26
110.54
54.49
-1.00
Interest
4.50
2.99
0.60
0.00
0.83
0.28
0.01
Exceptional Items
2.34
2.73
-0.05
0.00
0.00
0.18
0.02
Gross Profit (PBDT)
416.96
415.91
365.56
292.70
187.97
128.39
36.24
Depreciation
96.91
62.29
47.00
0.00
18.35
7.53
0.67
Profit Before Tax
122.37
160.63
175.22
143.31
91.35
46.86
-1.66
Tax
9.40
2.37
9.02
18.39
14.92
12.13
4.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
109.82
158.91
164.67
124.93
76.43
34.74
-6.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
109.82
158.91
164.67
124.93
76.43
34.74
-6.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
-0.01
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
109.82
158.91
164.67
124.93
76.43
34.73
-6.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,134.73
2,124.66
1,977.71
785.63
657.24
240.47
27.74
Earnings per share (EPS)
0.27
0.39
0.4
0.3
0.19
0.08
-0.01
Diluted Earnings per share
0.27
0.39
0.4
0.3
0.19
0.08
-0.01
Operating Profit Margin (Excl OI)
13.4%
17.93%
19.43%
36.38%
18.84%
11.35%
-21.21%
Gross Profit Margin
32.11%
35.98%
43.16%
36.39%
42.0%
28.29%
-1.86%
PAT Margin
16.08%
25.65%
31.98%
31.72%
29.26%
18.07%
-11.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 10.23% vs 20.34% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -30.90% vs -3.52% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 8.65% vs 17.88% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 50.00% vs 400.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of GemPharmatech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
682.94
0
682.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
682.94
0
682.94
Raw Material Cost
265.98
0
265.98
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.50
0
4.50
Selling and Distribution Expenses
242.96
0
242.96
Other Expenses
7.77
0.00
7.77
Total Expenditure (Excl Depreciation)
591.15
0
591.15
Operating Profit (PBDIT) excl Other Income
91.79
0.00
91.79
Other Income
33.01
0
33.01
Operating Profit (PBDIT)
221.44
0
221.44
Interest
4.50
0
4.50
Exceptional Items
2.34
0
2.34
Gross Profit (PBDT)
416.96
0
416.96
Depreciation
96.91
0
96.91
Profit Before Tax
122.37
0
122.37
Tax
9.40
0
9.40
Provisions and contingencies
0
0
0.00
Profit After Tax
109.82
0
109.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
109.82
0
109.82
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
109.82
0
109.82
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,134.73
0
2,134.73
Earnings per share (EPS)
0.27
0
0.27
Diluted Earnings per share
0.27
0
0.27
Operating Profit Margin (Excl OI)
13.40%
0%
0.00
13.40%
Gross Profit Margin
32.11%
0%
0.00
32.11%
PAT Margin
16.08%
0%
0.00
16.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 68.29 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.23% vs 20.34% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 10.98 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -30.90% vs -3.52% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.84 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 8.65% vs 17.88% in Dec 2023
Annual - Interest
Interest 0.45 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 50.00% vs 400.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.40%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






